PE20020406A1 - 7-OXO-PYRIDO [2,3-d] PYRIMIDINES 2,6-DISUSTITUTED AS INHIBITORS OF PROTEIN KINASES - Google Patents
7-OXO-PYRIDO [2,3-d] PYRIMIDINES 2,6-DISUSTITUTED AS INHIBITORS OF PROTEIN KINASESInfo
- Publication number
- PE20020406A1 PE20020406A1 PE2001000860A PE2001000860A PE20020406A1 PE 20020406 A1 PE20020406 A1 PE 20020406A1 PE 2001000860 A PE2001000860 A PE 2001000860A PE 2001000860 A PE2001000860 A PE 2001000860A PE 20020406 A1 PE20020406 A1 PE 20020406A1
- Authority
- PE
- Peru
- Prior art keywords
- disustituted
- pyrido
- pyrimidines
- oxo
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A 7-OXO-PIRIDO[2,3-d]PIRIMIDINAS 2,6 DISUSTITUIDAS DE FORMULA I DONDE R1 ES H, ALQUILO; R2 ES CICLOALQUILO, CICLOALQUILO HETEROSUSTITUIDO, ARALCOXI, ALCOXI, HETEROCICLICLO, ENTRE OTROS; R3 ES H, AMINO, MONOALQUILOAMINO, DIALQUILAMINO, ACILAMINO, ALQUILO, CICLOLAQUILO, -NRa-C(=O)-Rb, ENTRE OTROS DONDE Ra ES H, ALQUILO; Rb ES HETEROCICLILO, HETEROALQUILO; AR1 Y AR2 SON ARILO. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION. SON COMPUESTOS PREFERIDOS LOS COMPUESTOS DE FORMULA II DONDE AR1 ES FENILO. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LAS PROTEINA CINASAS Y SON UTILES PARA EL TRATAMIENTO DE ARTRITIS, ENFERMEDAD DE CROHN, ALZHEIMERREFERS TO 7-OXO-PYRIDO [2,3-d] PYRIMIDINES 2,6 DISUSTITUTED OF FORMULA I WHERE R1 IS H, ALKYL; R2 IS CYCLOALKYL, HETEROSUSTITUTED CYCLOALKYL, ARALCOXI, ALCOXI, HETERO CYCLE, AMONG OTHERS; R3 IS H, AMINO, MONOALKYLAMINE, DIALKYLAMINE, ACILAMINE, ALKYL, CYCLOLAKYL, -NRa-C (= O) -Rb, AMONG OTHERS WHERE Ra IS H, ALKYL; Rb IS HETEROCYCLYL, HETEROALKYL; AR1 AND AR2 ARE ARYL. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. THE PREFERRED COMPOUNDS ARE THE COMPOUNDS OF FORMULA II WHERE AR1 IS PHENYL. THE MENTIONED COMPOUNDS ARE INHIBITORS OF PROTEIN KINASES AND ARE USEFUL FOR THE TREATMENT OF ARTHRITIS, CROHN'S DISEASE, ALZHEIMER
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22958400P | 2000-08-31 | 2000-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020406A1 true PE20020406A1 (en) | 2002-05-17 |
Family
ID=22861859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000860A PE20020406A1 (en) | 2000-08-31 | 2001-08-28 | 7-OXO-PYRIDO [2,3-d] PYRIMIDINES 2,6-DISUSTITUTED AS INHIBITORS OF PROTEIN KINASES |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1315726A1 (en) |
JP (1) | JP4141830B2 (en) |
KR (1) | KR100571339B1 (en) |
CN (1) | CN1275964C (en) |
AR (1) | AR033681A1 (en) |
AU (2) | AU9378401A (en) |
BR (1) | BR0113628A (en) |
CA (1) | CA2420286A1 (en) |
GT (1) | GT200100191A (en) |
MX (1) | MXPA03001821A (en) |
PA (1) | PA8527301A1 (en) |
PE (1) | PE20020406A1 (en) |
UY (1) | UY26918A1 (en) |
WO (1) | WO2002018380A1 (en) |
ZA (1) | ZA200301079B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6518276B2 (en) | 2000-08-31 | 2003-02-11 | Syntex (U.S.A.) Llc | 7-oxo-pyridopyrimidines (II) |
AU2002212147B2 (en) * | 2000-08-31 | 2007-10-18 | F. Hoffmann-La Roche Ag | 7-OXO pyridopyrimidines |
JP2006503802A (en) * | 2002-04-03 | 2006-02-02 | エフ.ホフマン−ラ ロシュ アーゲー | Imidazo condensation compounds |
DE60315826T2 (en) * | 2002-04-19 | 2008-05-21 | Smithkline Beecham Corp. | NEW CONNECTIONS |
US7084270B2 (en) | 2002-08-14 | 2006-08-01 | Hoffman-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
UY27939A1 (en) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | COMPOUNDS |
US7129351B2 (en) | 2002-11-04 | 2006-10-31 | Hoffmann-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
MXPA05005028A (en) * | 2002-11-18 | 2005-08-03 | Hoffmann La Roche | Diazinopyrimidines. |
US7098332B2 (en) | 2002-12-20 | 2006-08-29 | Hoffmann-La Roche Inc. | 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones |
CN100497339C (en) | 2003-04-10 | 2009-06-10 | 霍夫曼-拉罗奇有限公司 | Pyrimido compounds |
WO2005007193A2 (en) * | 2003-07-07 | 2005-01-27 | Vande Woude, George, F. | Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
PL1685131T3 (en) * | 2003-11-13 | 2007-08-31 | Hoffmann La Roche | Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
WO2005105097A2 (en) * | 2004-04-28 | 2005-11-10 | Gpc Biotech Ag | Pyridopyrimidines for treating inflammatory and other diseases |
US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
US20090131430A1 (en) * | 2004-11-23 | 2009-05-21 | Palle Venkata P | Pyrido'2,3-dipyrimidines as anti-inflammatory agents |
EP1846403A1 (en) * | 2005-02-02 | 2007-10-24 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as anti-inflammatory agents |
EP1931667A1 (en) * | 2005-09-28 | 2008-06-18 | Ranbaxy Laboratories Limited | Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
JP2009525292A (en) | 2006-01-31 | 2009-07-09 | エフ.ホフマン−ラ ロシュ アーゲー | 7H-pyrido [3,4-D] pyrimidin-8-ones, their preparation and use as protein kinase inhibitors |
KR100661523B1 (en) * | 2006-06-09 | 2006-12-26 | 주식회사 청용산기 | Box correcting device of stitching progress for carton box erecting |
EP1914234A1 (en) | 2006-10-16 | 2008-04-23 | GPC Biotech Inc. | Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors |
WO2008055842A1 (en) | 2006-11-09 | 2008-05-15 | F. Hoffmann-La Roche Ag | Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
WO2008078249A1 (en) * | 2006-12-21 | 2008-07-03 | Ranbaxy Laboratories Limited | Anti-inflammatory agents |
EP2112150B1 (en) | 2008-04-22 | 2013-10-16 | Forma Therapeutics, Inc. | Improved raf inhibitors |
KR101106162B1 (en) * | 2010-04-20 | 2012-01-20 | 주식회사 청용산기 | Stitching device for packing box making apparatus |
AU2013235344B2 (en) * | 2012-03-22 | 2017-03-16 | Oscotec Inc. | Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors |
NZ711376A (en) | 2013-03-15 | 2020-01-31 | Sanofi Sa | Heteroaryl compounds and uses thereof |
TWI647220B (en) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | Heteroaryl compound and its use |
AU2014228746B2 (en) | 2013-03-15 | 2018-08-30 | Celgene Car Llc | Heteroaryl compounds and uses thereof |
WO2016037255A2 (en) | 2014-09-12 | 2016-03-17 | Biolab Sanus Farmacêutica Ltda. | New pyridopyrimidines derivatives compounds |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
PT3691620T (en) | 2017-10-05 | 2022-10-06 | Fulcrum Therapeutics Inc | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
EP3941919A1 (en) * | 2019-01-03 | 2022-01-26 | Genentech, Inc. | Pyrido-pyrimidinone and pteridinone compounds as inhibitors of endoribonuclease inositol requiring enzyme i (ire i alpha) for the treatment of cancer diseases |
US20220251081A1 (en) * | 2019-05-31 | 2022-08-11 | Les Laboratoires Servier | Heterobicyclic inhibitors of mat2a and methods of use for treating cancer |
WO2022052924A1 (en) * | 2020-09-11 | 2022-03-17 | 上海凌达生物医药有限公司 | Preparation method for class of nitrogen-containing fused ring compounds and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2146782T3 (en) * | 1994-11-14 | 2000-08-16 | Warner Lambert Co | 6-ARYL-PIRIDO (2,3-D) PIRIMIDINAS AND NAFTIRIDINAS FOR THE INHIBITION OF THE CELL PROLIFERATION INDUCED BY THE PROTEIN TIROSINA QUINASA. |
IL117923A (en) * | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
AU763839B2 (en) * | 1998-05-26 | 2003-07-31 | Warner-Lambert Company | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
-
2001
- 2001-08-22 CA CA002420286A patent/CA2420286A1/en not_active Abandoned
- 2001-08-22 AU AU9378401A patent/AU9378401A/en active Pending
- 2001-08-22 CN CNB018150306A patent/CN1275964C/en not_active Expired - Fee Related
- 2001-08-22 WO PCT/EP2001/009689 patent/WO2002018380A1/en not_active Application Discontinuation
- 2001-08-22 BR BR0113628-3A patent/BR0113628A/en not_active Application Discontinuation
- 2001-08-22 KR KR1020037002936A patent/KR100571339B1/en not_active IP Right Cessation
- 2001-08-22 JP JP2002523895A patent/JP4141830B2/en not_active Expired - Fee Related
- 2001-08-22 EP EP01974206A patent/EP1315726A1/en not_active Withdrawn
- 2001-08-22 MX MXPA03001821A patent/MXPA03001821A/en active IP Right Grant
- 2001-08-22 AU AU2001293784A patent/AU2001293784B2/en not_active Ceased
- 2001-08-28 PA PA20018527301A patent/PA8527301A1/en unknown
- 2001-08-28 PE PE2001000860A patent/PE20020406A1/en not_active Application Discontinuation
- 2001-08-30 AR ARP010104132A patent/AR033681A1/en unknown
- 2001-08-30 UY UY26918A patent/UY26918A1/en not_active Application Discontinuation
- 2001-09-18 GT GT200100191A patent/GT200100191A/en unknown
-
2003
- 2003-02-07 ZA ZA200301079A patent/ZA200301079B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030022422A (en) | 2003-03-15 |
KR100571339B1 (en) | 2006-04-17 |
WO2002018380A1 (en) | 2002-03-07 |
AR033681A1 (en) | 2004-01-07 |
JP4141830B2 (en) | 2008-08-27 |
CN1275964C (en) | 2006-09-20 |
CN1451005A (en) | 2003-10-22 |
GT200100191A (en) | 2002-05-16 |
CA2420286A1 (en) | 2002-03-07 |
AU9378401A (en) | 2002-03-13 |
UY26918A1 (en) | 2002-02-28 |
PA8527301A1 (en) | 2002-07-30 |
MXPA03001821A (en) | 2003-06-04 |
BR0113628A (en) | 2003-07-01 |
ZA200301079B (en) | 2004-05-07 |
EP1315726A1 (en) | 2003-06-04 |
JP2004507541A (en) | 2004-03-11 |
AU2001293784B2 (en) | 2007-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20020406A1 (en) | 7-OXO-PYRIDO [2,3-d] PYRIMIDINES 2,6-DISUSTITUTED AS INHIBITORS OF PROTEIN KINASES | |
PE20120814A1 (en) | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | |
PE20070218A1 (en) | AMINO-HYDANTOIN CYCLOALKYL COMPOUNDS AND USE OF THESE FOR THE MODULATION OF ß-SECRETASE | |
EA200501333A1 (en) | 5,7-DIAMINOPYRAZOLO [4,3-d] Pyrimidines, useful in the treatment of hypertension | |
PE20010211A1 (en) | THIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEIN KINASES | |
PE20030471A1 (en) | IMIDAZOPIRIDIN COMPOUND AS 5-HT4 RECEIVER MODULATORS | |
EA200100971A1 (en) | NEW COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | |
PE20030129A1 (en) | IMIDAZOTRIAZINES | |
PE20130012A1 (en) | PIRAZOLE DERIVATIVES AS JAK INHIBITORS | |
EA200200716A1 (en) | ARYL CONDENSED AZOPOLYCYCLIC COMPOUNDS | |
UY26872A1 (en) | DERIVATIVES OF THE 4- PIRIDINE PHENYL | |
ECSP034744A (en) | N-REPLACED N-REPLACED NMDA / NR2B ANTAGONISTS | |
EA200200337A1 (en) | DERIVATIVES OF PYRAZOLO [4,3-d] PYRIMIDINE | |
ATE469892T1 (en) | SUBSTITUTED 1H-DIHYDROPYRAZOLES, THEIR PREPARATION AND USE | |
ECSP045229A (en) | PIRIDINONES REPLACED AS MODULATORS OF THE P38 MAP QUINASA | |
AR051735A1 (en) | PIRROLIC INHIBITORS OF THE PROTEIN QUINASA ERK, SYNTHESIS AND INTERMEDIARIES OF THE SAME. | |
BR0008056A (en) | Substituted fused pyrrolocarbazoles and cyclic isoindolones | |
BG66085B1 (en) | Phenylalanine derivatives | |
EA200600973A1 (en) | PYRIDO [2,3-d] PYRIMIDIN-2,4-DIAMINS AS PDE 2 INHIBITORS | |
HRP20050390A2 (en) | Substituted benzoxazinones and uses thereof | |
PE20011066A1 (en) | PYRID [2,3-d] PYRIMIDIN-2,7-DIAMINES KINE INHIBITORS | |
PE20061067A1 (en) | PYRIMIDINE DERIVATIVES | |
PE20060355A1 (en) | I HAVE [3,2-b] PYRIDIN-6-CARBONITRILS AS INHIBITORS OF PROTEIN KINASE | |
AR054508A1 (en) | BENCILPIPERAZINE COMPOSITE, ITS USE TO PREPARE A MEDICINAL PRODUCT, PROCEDURES FOR THE PREPARATION OF SUCH COMPOUND AND INTERMEDIATE COMPOUNDS, SUCH INTERMEDIARY COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE IT | |
EA200600605A1 (en) | REJUVENATED PENTANOLS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |